These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 36732545)

  • 1. Time to fellow eye involvement in patients with unilateral diabetic macular oedema.
    Alsaloum P; Russell MW; Blaga V; Kuo BL; Wu AK; Liu BJ; Valentim CCS; Xu CM; Muste JC; Kumar M; Singh RP
    Eye (Lond); 2023 Sep; 37(13):2761-2767. PubMed ID: 36732545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optical coherence tomography (OCT) for detection of macular oedema in patients with diabetic retinopathy.
    Virgili G; Menchini F; Casazza G; Hogg R; Das RR; Wang X; Michelessi M
    Cochrane Database Syst Rev; 2015 Jan; 1(1):CD008081. PubMed ID: 25564068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monotherapy laser photocoagulation for diabetic macular oedema.
    Jorge EC; Jorge EN; Botelho M; Farat JG; Virgili G; El Dib R
    Cochrane Database Syst Rev; 2018 Oct; 10(10):CD010859. PubMed ID: 30320466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-vascular endothelial growth factor for diabetic macular oedema.
    Virgili G; Parravano M; Menchini F; Evans JR
    Cochrane Database Syst Rev; 2014 Oct; (10):CD007419. PubMed ID: 25342124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-vascular endothelial growth factor for diabetic macular oedema: a network meta-analysis.
    Virgili G; Parravano M; Evans JR; Gordon I; Lucenteforte E
    Cochrane Database Syst Rev; 2018 Oct; 10(10):CD007419. PubMed ID: 30325017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-vascular endothelial growth factor for diabetic macular oedema: a network meta-analysis.
    Virgili G; Parravano M; Evans JR; Gordon I; Lucenteforte E
    Cochrane Database Syst Rev; 2017 Jun; 6(6):CD007419. PubMed ID: 28639415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The UK Diabetic Retinopathy Electronic Medical Record (UK DR EMR) Users Group, Report 2: real-world data for the impact of cataract surgery on diabetic macular oedema.
    Denniston AK; Chakravarthy U; Zhu H; Lee AY; Crabb DP; Tufail A; Bailey C; Akerele T; Al-Husainy S; Brand C; Downey L; Fitt A; Khan R; Kumar V; Lobo A; Mahmood S; Mandal K; Mckibbin M; Menon G; Natha S; Ong JM; Tsaloumas MD; Varma A; Wilkinson E; Johnston RL; Egan CA;
    Br J Ophthalmol; 2017 Dec; 101(12):1673-1678. PubMed ID: 28487377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optical coherence tomography (OCT) for detection of macular oedema in patients with diabetic retinopathy.
    Virgili G; Menchini F; Murro V; Peluso E; Rosa F; Casazza G
    Cochrane Database Syst Rev; 2011 Jul; (7):CD008081. PubMed ID: 21735421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Real-world management of treatment-naïve diabetic macular oedema: 2-year visual outcome focusing on the starting year of intervention
    Shimura M; Kitano S; Muramatsu D; Fukushima H; Takamura Y; Matsumoto M; Kokado M; Kogo J; Sasaki M; Morizane Y; Utsumi T; Koto T; Sonoda S; Hirano T; Ishikawa H; Mitamura Y; Okamoto F; Kinoshita T; Kimura K; Sugimoto M; Yamashiro K; Suzuki Y; Hikichi T; Washio N; Sato T; Ohkoshi K; Tsujinaka H; Kusuhara S; Kondo M; Takagi H; Murata T; Sakamoto T;
    Br J Ophthalmol; 2020 Dec; 104(12):1755-1761. PubMed ID: 32169861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-vascular endothelial growth factor for diabetic macular oedema: a network meta-analysis.
    Virgili G; Curran K; Lucenteforte E; Peto T; Parravano M
    Cochrane Database Syst Rev; 2023 Jun; 2023(6):CD007419. PubMed ID: 38275741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vitreomacular interface abnormalities in patients with diabetic macular oedema and their implications on the response to anti-VEGF therapy.
    Mikhail M; Stewart S; Seow F; Hogg R; Lois N
    Graefes Arch Clin Exp Ophthalmol; 2018 Aug; 256(8):1411-1418. PubMed ID: 29779188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fasting plasma glucose variability is an independent risk factor for diabetic retinopathy and diabetic macular oedema in type 2 diabetes: An 8-year prospective cohort study.
    Hsieh YT; Hsieh MC
    Clin Exp Ophthalmol; 2020 May; 48(4):470-476. PubMed ID: 32065699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Standard threshold laser versus subthreshold micropulse laser for adults with diabetic macular oedema: the DIAMONDS non-inferiority RCT.
    Lois N; Campbell C; Waugh N; Azuara-Blanco A; Maredza M; Mistry H; McAuley D; Acharya N; Aslam TM; Bailey C; Chong V; Downey L; Eleftheriadis H; Fatum S; George S; Ghanchi F; Groppe M; Hamilton R; Menon G; Saad A; Sivaprasad S; Shiew M; Steel DH; Talks JS; Doherty P; McDowell C; Clarke M
    Health Technol Assess; 2022 Dec; 26(50):1-86. PubMed ID: 36541393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiangiogenic therapy with anti-vascular endothelial growth factor modalities for diabetic macular oedema.
    Virgili G; Parravano M; Menchini F; Brunetti M
    Cochrane Database Syst Rev; 2012 Dec; 12():CD007419. PubMed ID: 23235642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-vascular endothelial growth factor combined with intravitreal steroids for diabetic macular oedema.
    Mehta H; Hennings C; Gillies MC; Nguyen V; Campain A; Fraser-Bell S
    Cochrane Database Syst Rev; 2018 Apr; 4(4):CD011599. PubMed ID: 29669176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of costs associated with the management and morbidity of diabetic macular oedema and macular oedema secondary to retinal vein occlusion.
    Abraldes MJ; Pareja A; Roura M;
    Arch Soc Esp Oftalmol; 2016 Jun; 91(6):273-80. PubMed ID: 26810908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optical coherence tomography angiography in pseudophakic cystoid macular oedema compared to diabetic macular oedema: qualitative and quantitative evaluation of retinal vasculature.
    Sacconi R; Corbelli E; Carnevali A; Mercuri S; Rabiolo A; Querques L; Marchini G; Bandello F; Querques G
    Br J Ophthalmol; 2018 Dec; 102(12):1684-1690. PubMed ID: 29463502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomised trial of wide-field guided PRP for diabetic macular oedema treated with ranibizumab.
    Talks SJ; Bhatia D; Menon G; Cole A; Eleftheriadis H; Downey L; Chong NV; Sivaprasad S;
    Eye (Lond); 2019 Jun; 33(6):930-937. PubMed ID: 30728488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. OCT-based biomarkers for predicting treatment response in eyes with centre-involved diabetic macular oedema treated with anti-VEGF injections: a real-life retina clinic-based study.
    Szeto SK; Hui VWK; Tang FY; Yang D; Sun ZH; Mohamed S; Chan CKM; Lai TYY; Cheung C
    Br J Ophthalmol; 2023 Apr; 107(4):525-533. PubMed ID: 34750100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vitreoretinal interface abnormalities in patients treatedwith ranibizumab for diabetic macular oedema.
    Wong Y; Steel DHW; Habib MS; Stubbing-Moore A; Bajwa D; Avery PJ;
    Graefes Arch Clin Exp Ophthalmol; 2017 Apr; 255(4):733-742. PubMed ID: 27957600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.